3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Polycythemia Vera
1
Interventions
Peripheral Blood Stem Cell Transplantation
2
spartalizumab
1
siltuximab
1
sabatolimab
1
ruxolitinib
1
pelcitoclax
1
fludarabine phosphate
1
ethanolamine oleate
1
durvalumab
1
Whole-Body Irradiation
1
Trimethoprim, Sulfamethoxazole Drug Combination
1
Trimethoprim
1
Tacrolimus
1
Sulfamethoxazole
1
Sodium Chloride
1
Saline Solution, Hypertonic
1
Saline Solution
1
Pentostatin
1
Pentetic Acid
1
Ondansetron
1
NIS-793
1
Mycophenolic Acid
1
Methotrexate
1
In Situ Hybridization, Fluorescence
1
Immunoglobulin G
1
Immunoenzyme Techniques
1
Flow Cytometry
1
Filgrastim
1
Ethanol
1
Edetic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Polycythemia Vera
×
Clopidogrel
×
Clear all
NCT00940784
2014-11-26
ISCLAP
Icahn School of Medicine at Mount Sinai
Phase 2
Withdrawn